Geftinib 250mg of glenmark

Get a Price/Quote

MOQ : 1 Box

Geftinib 250mg of glenmark Specification

Dosage Form
Oral tablet

Indication
Non-small cell lung cancer (NSCLC)

Salt Composition
Geftinib 250mg

Pacakaging (Quantity Per Box)
30 tablets per box

Origin of Medicine
India

Drug Type
Allopathic

Ingredients
Geftinib

Physical Form
Tablet

Function
Anti-cancer medication, Epidermal Growth Factor Receptor (EGFR) Inhibitor

Recommended For
Lung Cancer Treatment

Dosage
250mg

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
30 Tablets

Storage Instructions
Store below 30C, protected from moisture and light

Side Effects
Rash, diarrhea, nausea, vomiting, loss of appetite

Prescription Required
Yes

Therapeutic Class
Antineoplastic agents

Marketed By
Glenmark Pharmaceuticals

Contraindications
Known hypersensitivity to Geftinib or excipients

Route of Administration
Oral

Shelf Life
24 Months

Use
Oncology - Lung cancer treatment

Shape
Round

Color
White

About Geftinib 250mg of glenmark

Experience elite cancer care with Geftinib 250mg by Glenmark Pharmaceuticals, a resplendent choice for treating non-small cell lung cancer (NSCLC). This illustrious anti-cancer medication, in pristine white round tablets, inhibits Epidermal Growth Factor Receptors (EGFR), offering targeted therapy for adults. Each box contains 30 tablets, manufactured under stringent conditions in India. Prescription required. Add to Cart today and benefit from exclusive discounts. Store below 30C, shielded from moisture and light, and follow your physician's exact dosage instructions for optimal safety.

Geftinib 250mg: Expanding Horizons in Oncology

Beyond its prominent application in NSCLC, Geftinib 250mg may provide potential benefits in selected off-label clinical settings under strict medical supervision. Utilizing premium allopathic formulations, these tablets offer an advantage with their precise EGFR-inhibiting action, contributing to improved outcomes. The material's feature of being easy-to-swallow and precisely dosed supports adherence, while stringent manufacturing practices assure quality and consistent potency.

Geftinib 250mg: Sample, Delivery, and Shipping Information

Samples of Geftinib 250mg are available upon request to accommodate qualified buyers. Inquire about the asking price and secure your order with confidence. Expect a swift handover of shipped goods, typically within standard delivery timelines. Goods are dispatched from India's leading FOB ports, ensuring efficient logistics for distributors, suppliers, and traders. Every shipment is managed with a commitment to product integrity and customer satisfaction.

FAQ's of Geftinib 250mg of glenmark:

Q: How should Geftinib 250mg tablets of Glenmark be taken?

A: Geftinib 250mg tablets must be taken orally, exactly as prescribed by your physician, typically once daily with or without food. Always follow your doctor's dosage guidelines.

Q: What is the main therapeutic use of Geftinib 250mg?

A: Geftinib 250mg is primarily indicated for the treatment of non-small cell lung cancer (NSCLC), acting as an EGFR inhibitor that targets cancer cell growth.

Q: When should I avoid using Geftinib 250mg?

A: Do not use Geftinib 250mg if you have a known hypersensitivity to Geftinib or any of its excipients. Consult your healthcare provider regarding any contraindications.

Q: Where is Geftinib 250mg manufactured and marketed?

A: Geftinib 250mg is produced and marketed by Glenmark Pharmaceuticals in India, ensuring high standards of quality.

Q: What are some possible side effects of taking Geftinib 250mg?

A: Common side effects include rash, diarrhea, nausea, vomiting, and loss of appetite. Contact your healthcare provider if you experience severe or persistent symptoms.

Q: How does Geftinib 250mg provide an advantage in lung cancer treatment?

A: Geftinib 250mg advantageously targets the Epidermal Growth Factor Receptor (EGFR), leading to more effective inhibition of cancer cell proliferation in NSCLC.

Tell us about your requirement